论文部分内容阅读
目的:本次研究通过分析奥美拉唑和泮托拉唑。方法:本次研究主要选取本院2015年6月至2016年7月所收治的56例消化性溃疡出血患者为研究对象。将患者分为研究组和对照组两组,研究组、对照组患者人数均为28例。其中对照组患者采取的治疗方法为泮托拉唑治疗方法,研究组患者给予的治疗方法为奥美拉唑治疗方法。分析两组患者在治疗过程中患者的治疗效果,以及不良反应的发生情况。结果:根据本次研究中最终提供的数据显示,在治疗效果上两组患者的治疗效果都差不多,且P>0.05(差异并无统计学意义),但是在不良反应的发生率方面,研究组患者不良反应的发生率明显要低于对照组,且P<0.05(两组之间差异具有统计学意义)。结论:根据本次研究结果显示,相比较之下,对于消化性溃疡出血患者来说,奥美拉唑虽然在治疗效果方面与泮托拉唑差不多,但是奥美拉唑的安全性更高,能够有效减缓患者的痛苦,具有一定临床价值,值得推广使用。
Purpose: This study analyzed omeprazole and pantoprazole. Methods: The study selected 56 patients with peptic ulcer bleeding in our hospital from June 2015 to July 2016 as the research object. The patients were divided into two groups: study group and control group. The number of study group and control group were 28 cases. Among them, patients in the control group were treated with pantoprazole. Patients in the study group were treated with omeprazole. Analysis of two groups of patients in the course of treatment of patients with treatment, as well as the incidence of adverse reactions. RESULTS: Based on the data finally provided in this study, the efficacy of treatment was similar in both groups with P> 0.05 (the difference was not statistically significant), but in the incidence of adverse events, the study group The incidence of adverse reactions in patients was significantly lower than the control group, and P <0.05 (the difference between the two groups was statistically significant). CONCLUSIONS: According to the results of this study, omeprazole is comparable to pantoprazole for the treatment of patients with peptic ulcer, although omeprazole is similar in efficacy to treatment, but omeprazole is more safe, Can effectively alleviate the suffering of patients with a certain clinical value, it is worth promoting the use of.